Cycurion (NASDAQ:CYCU) versus Black Titan (NASDAQ:BTTC) Financial Review

Cycurion (NASDAQ:CYCU) and Black Titan (NASDAQ:BTTC) are both technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Profitability

This table compares Cycurion and Black Titan’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cycurion	N/A	N/A	N/A
Black Titan	N/A	N/A	N/A

Valuation and Earnings

This table compares Cycurion and Black Titan”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cycurion	$14.40 million	0.51	-$79.59 million	($24.64)	-0.09
Black Titan	N/A	N/A	N/A	($2.95)	-0.12

Black Titan has lower revenue, but higher earnings than Cycurion. Black Titan is trading at a lower price-to-earnings ratio than Cycurion, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

6.6% of Cycurion shares are held by institutional investors. 4.6% of Cycurion shares are held by company insiders. Comparatively, 0.7% of Black Titan shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Cycurion and Black Titan, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cycurion	1	1	1	0	2.00
Black Titan	1	0	0	0	1.00

Cycurion currently has a consensus price target of $56.00, indicating a potential upside of 2,345.41%. Given Cycurion’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Cycurion is more favorable than Black Titan.

Summary

Cycurion beats Black Titan on 7 of the 8 factors compared between the two stocks.

About Cycurion

Cycurion is a global leading provider of Network Communications and Information Technology Security Solutions. Our mission is to develop and deliver world-class, cutting-edge solutions for our clients, regardless of size or complication, expressly optimizing your IT environment to meet the business need and to keep projects on track and on budget.

About Black Titan

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.